Financhill
Sell
50

III Quote, Financials, Valuation and Earnings

Last price:
$3.36
Seasonality move :
4.75%
Day range:
$3.33 - $3.50
52-week range:
$2.92 - $4.98
Dividend yield:
5.34%
P/E ratio:
--
P/S ratio:
0.65x
P/B ratio:
1.71x
Volume:
245.1K
Avg. volume:
108.1K
1-year change:
-28.6%
Market cap:
$165.4M
Revenue:
$291.1M
EPS (TTM):
-$0.07
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $265.8M $249.1M $277.8M $286.3M $291.1M
Revenue Growth (YoY) -3.63% -6.26% 11.52% 3.04% 1.67%
 
Cost of Revenues $153.2M $149.9M $168.5M $169.7M $178.9M
Gross Profit $112.6M $99.3M $109.4M $116.6M $112.1M
Gross Profit Margin 42.36% 39.84% 39.36% 40.74% 38.53%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $92.5M $83.8M $78.8M $81.8M $91.3M
Other Inc / (Exp) -$146K -$98K $44K $170K -$158K
Operating Expenses $99.2M $90M $84.1M $87.1M $97.5M
Operating Income $13.4M $9.3M $25.3M $29.5M $14.6M
 
Net Interest Expenses $6.1M $3.3M $2.2M $3M $5.7M
EBT. Incl. Unusual Items $7.1M $5.9M $23.1M $26.7M $8.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $3.8M $3.1M $7.6M $7M $2.6M
Net Income to Company $3.3M $2.8M $15.5M $19.7M $6.2M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $3.3M $2.8M $15.5M $19.7M $6.2M
 
Basic EPS (Cont. Ops) $0.07 $0.06 $0.32 $0.41 $0.13
Diluted EPS (Cont. Ops) $0.07 $0.06 $0.30 $0.39 $0.12
Weighted Average Basic Share $46.9M $47.7M $48.6M $48.2M $48.6M
Weighted Average Diluted Share $47.6M $50M $51.8M $50.4M $50.2M
 
EBITDA $20.1M $15.6M $30.8M $35.2M $21.2M
EBIT $13.4M $9.4M $25.5M $29.8M $15M
 
Revenue (Reported) $265.8M $249.1M $277.8M $286.3M $291.1M
Operating Income (Reported) $13.4M $9.3M $25.3M $29.5M $14.6M
Operating Income (Adjusted) $13.4M $9.4M $25.5M $29.8M $15M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $61.6M $71.1M $68.8M $71.8M $61.3M
Revenue Growth (YoY) -9.55% 15.35% -3.18% 4.27% -14.62%
 
Cost of Revenues $36.8M $43.2M $39.8M $43M $36.5M
Gross Profit $24.9M $27.8M $29.1M $28.7M $24.7M
Gross Profit Margin 40.36% 39.17% 42.2% 40.04% 40.39%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $20.3M $19.2M $20.3M $21M $18.9M
Other Inc / (Exp) -$66K $1K $131K -$2K -$30K
Operating Expenses $21.9M $20.6M $21.6M $22.5M $20.5M
Operating Income $3M $7.3M $7.4M $6.2M $4.3M
 
Net Interest Expenses $626K $473K $787K $1.4M $1.4M
EBT. Incl. Unusual Items $2.3M $6.8M $6.8M $4.8M $2.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $227K $2.4M $1.2M $1.6M $1.7M
Net Income to Company $2.1M $4.4M $5.6M $3.2M $1.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $2.1M $4.4M $5.6M $3.2M $1.1M
 
Basic EPS (Cont. Ops) $0.04 $0.09 $0.12 $0.07 $0.02
Diluted EPS (Cont. Ops) $0.04 $0.09 $0.11 $0.06 $0.02
Weighted Average Basic Share $47.9M $48.8M $47.9M $48.7M $48.9M
Weighted Average Diluted Share $49.9M $51.5M $49.8M $50.3M $50.2M
 
EBITDA $4.6M $8.7M $8.9M $7.9M $6.1M
EBIT $3M $7.3M $7.6M $6.3M $4.5M
 
Revenue (Reported) $61.6M $71.1M $68.8M $71.8M $61.3M
Operating Income (Reported) $3M $7.3M $7.4M $6.2M $4.3M
Operating Income (Adjusted) $3M $7.3M $7.6M $6.3M $4.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $248.2M $274.7M $281.7M $299M $256M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $148.1M $165.8M $166.2M $182.6M $157.4M
Gross Profit $100.2M $108.9M $115.5M $116.4M $98.6M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $83M $81.8M $80.8M $85M $90.3M
Other Inc / (Exp) -$104K -$114K $295K -$118K -$142K
Operating Expenses $89.3M $87.3M $86M $91.1M $96.6M
Operating Income $10.9M $21.6M $29.5M $25.3M $2.1M
 
Net Interest Expenses $4.1M $2.2M $2.5M $5.5M $5.3M
EBT. Incl. Unusual Items $6.6M $19.3M $27.3M $19.7M -$3.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $3.2M $5.9M $8.3M $6.4M -$291K
Net Income to Company $3.4M $13.4M $19M $13.3M -$3.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $3.4M $13.4M $19M $13.3M -$3.1M
 
Basic EPS (Cont. Ops) $0.06 $0.27 $0.39 $0.28 -$0.07
Diluted EPS (Cont. Ops) $0.06 $0.27 $0.38 $0.27 -$0.07
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $17.3M $27.3M $35.1M $31.7M $9.1M
EBIT $11M $21.8M $29.8M $25.5M $2.8M
 
Revenue (Reported) $248.2M $274.7M $281.7M $299M $256M
Operating Income (Reported) $10.9M $21.6M $29.5M $25.3M $2.1M
Operating Income (Adjusted) $11M $21.8M $29.8M $25.5M $2.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $182.7M $208.3M $212.1M $224.9M $189.8M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $111.5M $127.4M $125.1M $138M $116.5M
Gross Profit $71.2M $80.9M $87M $86.8M $73.3M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $60.8M $58.8M $60.8M $64M $63M
Other Inc / (Exp) $14K -$2K $249K -$40K -$24K
Operating Expenses $65.4M $62.7M $64.7M $68.7M $67.8M
Operating Income $5.8M $18.1M $22.3M $18.1M $5.6M
 
Net Interest Expenses $2.7M $1.6M $1.9M $4.4M $4M
EBT. Incl. Unusual Items $3.1M $16.5M $20.7M $13.7M $1.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.8M $4.6M $5.2M $4.7M $1.8M
Net Income to Company $1.3M $12M $15.4M $9M -$203K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.3M $12M $15.4M $9M -$203K
 
Basic EPS (Cont. Ops) $0.02 $0.24 $0.32 $0.19 -$0.01
Diluted EPS (Cont. Ops) $0.02 $0.24 $0.31 $0.18 -$0.01
Weighted Average Basic Share $142.8M $145.6M $144.6M $145.6M $146.2M
Weighted Average Diluted Share $146.2M $155.1M $151.9M $150.9M $148.2M
 
EBITDA $10.6M $22.3M $26.6M $23.1M $11M
EBIT $6M $18.3M $22.7M $18.4M $6.3M
 
Revenue (Reported) $182.7M $208.3M $212.1M $224.9M $189.8M
Operating Income (Reported) $5.8M $18.1M $22.3M $18.1M $5.6M
Operating Income (Adjusted) $6M $18.3M $22.7M $18.4M $6.3M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $18.2M $43.7M $47.5M $30.6M $22.6M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $48.4M $45.5M $45.5M $47.6M $51.8M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets $4.6M $3.4M $4.2M $4.7M $8.1M
Total Current Assets $99.8M $114.6M $116.1M $115.5M $112.8M
 
Property Plant And Equipment $12.6M $10.9M $10.6M $12.7M $13.9M
Long-Term Investments -- -- -- -- --
Goodwill $85.3M $91M $90.8M $95M $97.2M
Other Intangibles $16.6M $15.1M $12.4M $14.4M $12.6M
Other Long-Term Assets $825K $5.7M $4.7M $2.7M $6M
Total Assets $218.8M $239.5M $236.8M $243M $247.3M
 
Accounts Payable $8.9M $11.2M $16.2M $15.9M $11.3M
Accrued Expenses $3.4M $14.6M $10.9M $14.7M $19.7M
Current Portion Of Long-Term Debt $11M $4.3M $4.3M $4.3M --
Current Portion Of Capital Lease Obligations $3M $2.6M $2.5M $2.4M $2.6M
Other Current Liabilities $5.8M $7.5M $8M $5.1M $2.4M
Total Current Liabilities $41.3M $50.7M $56.8M $51.2M $46.3M
 
Long-Term Debt $74.8M $73.6M $69.5M $74.4M $79.2M
Capital Leases -- -- -- -- --
Total Liabilities $129.1M $140.4M $138.4M $142.6M $145.3M
 
Common Stock $48K $48K $49K $49K $49K
Other Common Equity Adj -- -- -- -- --
Common Equity $89.7M $99.1M $98.4M $100.4M $102.1M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $89.7M $99.1M $98.4M $100.4M $102.1M
 
Total Liabilities and Equity $218.8M $239.5M $236.8M $243M $247.3M
Cash and Short Terms $18.2M $43.7M $47.5M $30.6M $22.6M
Total Debt $85.8M $77.9M $73.8M $78.7M $79.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $38.1M $54.5M $19.7M $18.7M $9.7M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $66.2M $65.2M $72M $92.5M $60.7M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets $4.6M $3.6M $6.2M $7.3M $10.4M
Total Current Assets $108.9M $123.4M $97.9M $118.4M $96.9M
 
Property Plant And Equipment $10M $9.9M $9.2M $10.8M $12.4M
Long-Term Investments -- -- -- -- --
Goodwill $90.8M $90.8M $90.4M $94.9M $87.5M
Other Intangibles $16M $13.1M $10.8M $12M $3.9M
Other Long-Term Assets $1M $4.2M $2.1M $4.3M $20.9M
Total Assets $230.1M $243.5M $214M $243.6M $227.1M
 
Accounts Payable $9.4M $15.7M $9.7M $11.8M $8.8M
Accrued Expenses $25.6M $34.9M $22.6M $22.5M $22.7M
Current Portion Of Long-Term Debt -- $4.3M $4.3M -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- $7.8M
Total Current Liabilities $43.9M $61.9M $43.6M $40.9M $49.2M
 
Long-Term Debt $74.6M $70.5M $66.4M $79.2M $66.2M
Capital Leases -- -- -- -- --
Total Liabilities $136.5M $145.2M $120.4M $137.9M $130.6M
 
Common Stock $48K $49K $49K $49K $50K
Other Common Equity Adj -- -- -- -$9.9M -$8.9M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $93.6M $98.3M $93.6M $105.7M $96.6M
 
Total Liabilities and Equity $230.1M $243.5M $214M $243.6M $227.1M
Cash and Short Terms $38.1M $54.5M $19.7M $18.7M $9.7M
Total Debt $78.9M $74.8M $70.7M $79.2M $66.2M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $3.3M $2.8M $15.5M $19.7M $6.2M
Depreciation & Amoritzation $6.7M $6.2M $5.3M $5.4M $6.3M
Stock-Based Compensation $9.6M $8.9M $6.5M $7.5M $9.1M
Change in Accounts Receivable -$1.4M $10.1M $2.6M -$14M -$6.7M
Change in Inventories -- -- -- -- --
Cash From Operations $20.4M $44M $41.9M $11.1M $12.3M
 
Capital Expenditures $1.9M $1.2M $2.3M $3.4M $3.4M
Cash Acquisitions -- -$2.3M -- -$3.5M -$1M
Cash From Investing -$1.9M -$3.5M -$2.3M -$6.9M -$4.4M
 
Dividends Paid (Ex Special Dividend) -- -- -$4.4M -$7.5M -$8.7M
Special Dividend Paid
Long-Term Debt Issued -- -- -- $9M $84.2M
Long-Term Debt Repaid -$12.3M -$8.1M -$4.3M -$4.3M -$84.2M
Repurchase of Common Stock -$3.4M -$5.2M -$16.3M -$12.1M -$3.5M
Other Financing Activities -$4M -$3M -$9.7M -$5.1M -$4.9M
Cash From Financing -$18.9M -$15.7M -$34.1M -$18.9M -$16.2M
 
Beginning Cash (CF) $18.7M $18.2M $43.8M $47.6M $30.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$419K $24.8M $5.5M -$14.7M -$8.4M
Ending Cash (CF) $18.2M $43.8M $47.6M $30.7M $22.8M
 
Levered Free Cash Flow $18.5M $42.8M $39.6M $7.7M $8.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $2.1M $4.4M $5.6M $3.2M $1.1M
Depreciation & Amoritzation $1.6M $1.3M $1.3M $1.5M $1.6M
Stock-Based Compensation $2.2M $1.5M $2M $2.1M $2.3M
Change in Accounts Receivable $2.1M $4.2M -$3M -$5M $3.5M
Change in Inventories -- -- -- -- --
Cash From Operations $10.3M $18.5M -$341K $3.2M $8.8M
 
Capital Expenditures $368K $535K $510K $671K $389K
Cash Acquisitions -$2.3M -- -- -- --
Cash From Investing -$2.7M -$535K -$510K -$671K -$389K
 
Dividends Paid (Ex Special Dividend) -- -$1.5M -$2M -$2.3M -$2.3M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $5M $5M
Long-Term Debt Repaid -$1.1M -$1.1M -$1.1M -$5M -$13M
Repurchase of Common Stock -$277K -$2.1M -$2.5M -- -$385K
Other Financing Activities -$278K -$2.1M -$3.4M -$924K -$430K
Cash From Financing -$1.5M -$6.7M -$8.7M -$3M -$11M
 
Beginning Cash (CF) $31.6M $43.9M $31.6M $19.7M $11.9M
Foreign Exchange Rate Adjustment $416K -$605K -$2.2M -$379K $459K
Additions / Reductions $6.2M $11.3M -$9.6M -$543K -$2.6M
Ending Cash (CF) $38.2M $54.6M $19.8M $18.8M $9.8M
 
Levered Free Cash Flow $10M $18M -$851K $2.5M $8.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $3.4M $13.4M $19M $13.3M -$3.1M
Depreciation & Amoritzation $6.3M $5.5M $5.2M $6.2M $6.3M
Stock-Based Compensation $9M $7.4M $6.8M $8.8M $8.1M
Change in Accounts Receivable $17.5M $1.2M -$6M -$19.6M $10.2M
Change in Inventories -- -- -- -- --
Cash From Operations $51.9M $46.1M $7.1M $9.2M $23M
 
Capital Expenditures $1.6M $1.9M $3.4M $2.4M $4.1M
Cash Acquisitions -$2.3M -$35K -- -- --
Cash From Investing -$3.9M -$1.9M -$3.4M -$5.9M -$5.1M
 
Dividends Paid (Ex Special Dividend) -- -$2.9M -$6.9M -$8.5M -$7M
Special Dividend Paid
Long-Term Debt Issued -- -- -- $93.2M $10M
Long-Term Debt Repaid -$16.6M -$4.3M -$4.3M -$85.3M -$23M
Repurchase of Common Stock -$5.5M -$13.5M -$15M -$2M -$4.9M
Other Financing Activities -$3.2M -$6.9M -$7.7M -$5.1M -$3.8M
Cash From Financing -$24.8M -$27M -$33.1M -$6.7M -$27.8M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $23.3M $17.2M -$29.5M -$3.5M -$10M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $50.3M $44.2M $3.6M $6.7M $18.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $1.3M $12M $15.4M $9M -$203K
Depreciation & Amoritzation $4.6M $4M $3.9M $4.7M $4.7M
Stock-Based Compensation $6.5M $5.1M $5.4M $6.8M $5.7M
Change in Accounts Receivable $10.8M $1.9M -$6.8M -$12.4M $4.4M
Change in Inventories -- -- -- -- --
Cash From Operations $37.3M $39.5M $4.6M $2.6M $13.3M
 
Capital Expenditures $795K $1.5M $2.6M $1.6M $2.3M
Cash Acquisitions -$2.3M -- -- -- --
Cash From Investing -$3.1M -$1.5M -$2.6M -$1.6M -$2.3M
 
Dividends Paid (Ex Special Dividend) -- -$2.9M -$5.4M -$6.5M -$4.9M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $84.2M $10M
Long-Term Debt Repaid -$7M -$3.2M -$3.2M -$84.2M -$23M
Repurchase of Common Stock -$5.1M -$13.4M -$12.1M -$2M -$3.4M
Other Financing Activities -$2.8M -$6.7M -$4.7M -$4.7M -$3.6M
Cash From Financing -$14.5M -$25.8M -$24.8M -$12.6M -$24.2M
 
Beginning Cash (CF) $67.4M $136.4M $122.9M $74.2M $48.8M
Foreign Exchange Rate Adjustment $270K -$1.4M -$5M -$265K $158K
Additions / Reductions $19.7M $12.2M -$22.8M -$11.6M -$13.2M
Ending Cash (CF) $87.4M $147.1M $95.1M $62.4M $35.8M
 
Levered Free Cash Flow $36.5M $38M $2M $966K $11M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock